China NMPA Product Recall - Flexima Biliary Stent (Integrated Biliary Stent)

Boston Scientific Corporation initiated a global recall of its Flexima Biliary Stent system, as reported by the National Medical Products Administration (NMPA) on May 18, 2010. The recall, managed in China by Boston Scientific International Medical Trade (Shanghai) Co., Ltd., stemmed from an internal company inspection revealing a potential sealing defect in the sterile packaging. This defect could compromise the device's sterility, posing a health risk. While no patient complications had been reported, the company recognized the severity of the issue, particularly given the product's use in critical procedures like bile duct drainage. Under the NMPA's regulatory oversight, Boston Scientific implemented a comprehensive recall plan. This involved identifying all affected customers based on shipping records, issuing formal notifications through various channels, and arranging for the return of the compromised stents. The company aimed to complete these corrective actions by July 26, 2010, ensuring the removal of potentially non-sterile products from circulation across multiple affected regions, including China.